Not logged in
Talk
Contributions
Create account
Log in
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Page
Discussion
Edit
Edit source
View history
Editing
Available Guidelines: ESMO Guidelines
From Beacon
Jump to:
navigation
,
search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
<span style="display:none">europeanunion</span> Go back to [[Compilation: ESMO Guidelines (European Union)]] page Source: [https://www.esmo.org/guidelines/guidelines-by-topic Click here to learn more]. '''Breast Cancer''': * Metastatic Breast Cancer * Breast cancer in the COVID-19 era * Consensus Recommendations – Breast Cancer in Young Women (BCY5) * Early Breast Cancer * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes '''Cancers of Unknown Primary Site''': * Cancers of Unknown Primary Site '''Endocrine and Neuroendocrine Cancers''': * Adrenocortical Carcinomas and Malignant Phaeochromocytomas * Gastroenteropancreatic Neuroendocrine Neoplasms * Lung and Thymic Carcinoids * Thyroid cancer '''Gastrointestinal Cancers''': * Anal Cancer * Biliary Tract Cancer * Gastric Cancer * Gastrointestinal cancers: Colorectal cancer (CRC) in the COVID-19 era * Gastrointestinal cancers: Gastro-oesophageal tumours in the COVID-19 era * Gastrointestinal cancers: Pancreatic cancer in the COVID-19 era * Hepatocellular Carcinoma * Hereditary Gastrointestinal Cancers * Localised Colon Cancer * Metastatic Colorectal Cancer * Oesophageal Cancer; Pancreatic Cancer * Rectal Cancer '''Genitourinary Cancers''': * Bladder Cancer * Penile Carcinoma * Prostate Cancer * Renal Cell Carcinoma * Testicular Cancer '''Gynaecological Cancers''': * Cervical Cancer * Endometrial Cancer * Gestational Trophoblastic Disease * Gynaecological malignancies: Cervical cancer in the COVID-19 era * Gynaecological malignancies: Endometrial cancer in the COVID-19 era * Gynaecological malignancies: Epithelial ovarian cancer in the COVID-19 era * Newly Diagnosed and Relapsed Epithelial Ovarian Carcinoma * Non-Epithelial Ovarian Cancer * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes '''Haematological Malignancies''': * Acute Lymphoblastic Leukaemia * Acute Myeloid Leukaemia * Chronic Lymphocytic Leukaemia * Chronic Myeloid Leukaemia * Diffuse Large B-Cell Lymphoma * Elderly Patient with Malignant Lymphoma * Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma * Follicular Lymphoma * Hairy Cell Leukaemia * Hodgkin Lymphoma * Management of ultra-high-risk Patients * Mantle Cell Lymphoma * Marginal Zone Lymphomas * Multiple Myeloma * Myelodysplastic Syndromes * Peripheral T-Cell Lymphomas * Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms * Primary Cutaneous Lymphoma * Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia * Waldenstrom’s Macroglobulinaemia '''Head and Neck Cancers''': * Nasopharyngeal Carcinoma * Salivary Gland Cancer * Squamous Cell Carcinoma of the Head and Neck '''Hereditary Syndromes''': * Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes * Hereditary Gastrointestinal Cancers '''Lung and Chest Tumours''': * Early-Stage and Locally Advanced (non-metastatic) Non-Small-Cell Lung Cancer * Lung cancer in the COVID-19 era; Malignant Pleural Mesothelioma * Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer * Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer * Small-Cell Lung Cancer * Thymic Epithelial Tumours '''Melanoma''': * Cutaneous Melanoma '''Neuro-Oncology''': * Leptomeningeal Metastasis * High-Grade Malignant Glioma * Neurological and Vascular Complications of Primary and Secondary Brain Tumours * Brain Metastasis from Solid Tumours '''Sarcoma and GIST''': * Bone Sarcomas * Soft Tissue and Visceral Sarcomas * Gastrointestinal Stromal Tumours '''Supportive and Palliative Care''': * Palliative Care in the COVID-19 era * Advanced Care Planning * Anxiety and Depression * Anaemia and Iron Deficiency in Patients With Cancer * Bone Health in Cancer Patients * Cancer Cachexia in Adult Patients * Cancer Pain * Cancer-related Fatigue * Care at the End of Life * Central Venous Access in Oncology * Chemotherapy Extravasation * Constipation in Advanced Cancer * Delirium in Adult Cancer Patients * Diarrhoea in Adult Cancer Patients * Febrile Neutropaenia * Fertility Preservation and Post-treatment Pregnancies in Post-pubertal Cancer Patients * Infusion Reactions to Systemic Anticancer Therapy * Management of Breathlessness in Patients with Cancer * Management of Cardiac Disease; Management of Orphan Symptoms * Neurotoxicity; Oral and Gastrointestinal Mucosal Injury * Prevention and Management of Dermatological Toxicities Related to Anticancer Agents * Prevention of Chemotherapy and Radiotherapy-Induced Nausea and Vomiting * Prognostic Evaluation in Advanced Cancer * Role of Patient-reported Outcome Measures * Toxicities from immunotherapy and Venous Thromboembolism in Cancer Patients
Summary:
Please note that all contributions to Beacon may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Beacon:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Tools
What links here
Related changes
Special pages
Page information
